Blog Posts by Date: Oct 2021


California Bill Passes that Prohibits Prior Authorization for Biomarker Testing in Cancer Patients

On October 6, 2021, Senate Bill No. 535 was approved by Governor Gavin Newsom and filed with the Secretary of State in California. The bill will prohibit health insurance and health plans from requiring prior authorization for biomarker testing for an insured individual with advanced or metastatic stage 3 or 4 cancer, as well as biomarker testing...

Read



The Right Strategic Partnership Enables Pathology Practices to Maximize Financial Performance and Patient Care

Most of the individuals I know that have pursued careers in healthcare, have done so for one reason — they want to help people. With that responsibility it is inherent that patient care is a constant priority.  As revenue margins continue to compress under pressure due to reimbursement cuts and the increased cost of doing business, it is more...

Read



Transforming Diagnostic Service Delivery: One Lab’s Experience Integrating a Digital Pathology Platform and an LIS

Medicine has gone digital. This digital transformation can be seen in the rapid adoption of telemedicine, the use of digital radiology and medical imaging, and in precision medicine molecular and genomic testing. This post looks at how one laboratory, Cernostics, went digital through the implementation of a whole slide imaging and digital...

Read



Addressing EKRA Sales Force Compensation Mandates to Improve Both Compliance and Profitability

EKRA - Eliminating Kickbacks in Recovery Act - is a relatively new law that has some important implications for all diagnostic laboratories, and not just toxicology labs, which precipitated the legislation. Passed in October 2018, it was widely understood the law was intended to combat the opioid crisis. Recently, due in part to COVID-19 and...

Read